[Infographic] Opportunities and Challenges in Applying Artificial Intelligence and Digital Health Technologies in Viet Nam  

Digital health and artificial intelligence have the potential to transform healthcare, making health care management more efficient and accessible. However, a new paper by Ho Quang Chanh et al, detailed why engagement with policymakers, local patients and healthcare workers, and integrating with local systems and practice are crucial to ensure that digital health technologies can thrive in low- and middle-income settings.

Dengue Research Article Awarded The 2021 – 2022 Alexandre Yersin Prize for Outstanding Publications

Our research article titled ‘Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes’ was recently awarded the 2021-2022 Alexandre Yersin Prize for Outstanding Publications. This observational study was designed to identify severe dengue patients by using a series of inflammatory markers. The authors generated an immunological signature […]

First-of-its-kind study found equine antitoxin is safe and effective for the treatment of tetanus in adults

A first-of-its kind randomised controlled trial compared two different antitoxin treatments for tetanus. A comparison of human and equine intramuscular antitoxin in adults found that intramuscular equine antitoxin is safe and effective for treating tetanus in adults. Addition of additional intrathecal (spinal) antitoxin does not add any benefit compared to treatment with intramuscular antitoxin alone. […]

Picturing Health: The Burden of Leprosy in Eastern Indonesia

Leprosy impacts impoverished communities in low-income and middle-income countries (LMICs), with over 200,000 new cases recorded annually worldwide. This infectious disease is caused by Mycobacterium leprae or Mycobacterium lepromatosis and primarily affects the skin and peripheral nerves. Effective multidrug therapy is available, and, with early detection and treatment, leprosy is curable. Yet disease management can be complicated by immune-mediated […]

World TB Day 2022: Invest to End TB. Save Lives

Each year on 24 March, World TB Day is commemorated to raise awareness of this devastating and deadly disease. The theme for this year’s World TB Day is “Invest to End TB. Save Lives”, conveying the urgent need to invest resources to ramp up the fight against TB and achieve the commitments to end TB […]

OUCRU and Dragon Capital Group Announce Partnership on Intensive Care Development Programme for Life-Threatening Infectious Diseases in Vietnam

Oxford University Clinical Research Unit (OUCRU), a leading clinical and public health research unit, and Dragon Capital Group, an established financial institution focused on Vietnam and other Southeast Asian emerging markets, today announced a two-year partnership to support the development of high-quality intensive care for those with life-threatening infectious diseases in Vietnam. The emergence of […]

Tamoxifen repurposing study shows no benefit in treating deadly fungal meningitis

A drug repurposing study of tamoxifen for a deadly form of fungal meningitis suggests it has no benefits in clearing the infection more quickly. Hopes that tamoxifen could improve survival for a deadly form of fungal meningitis have been dashed by clinical trial results published in eLife. The study finds that adding tamoxifen to standard […]

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments. The Comprehensive Resistance Prediction for Tuberculosis International Consortium (CRyPTIC) research project has collected the largest ever global dataset of clinical M. tuberculosis samples […]

Study: Second most common malaria parasite takes unrealized toll on human health

The malaria parasite Plasmodium vivax (P. vivax) causes frequent, chronic infections that represent a major unrecognized burden on global health, according to a review by Kevin Baird of the Eijkman-Oxford Clinical Research Unit in Indonesia and Katherine Battle of the Institute for Disease Modeling in the United States publishing October 7th in the open access […]

OUCRU Director Guy Thwaites awarded MBE

OUCRU’s Director, Professor Guy Thwaites, was recently honoured in the 2021 Queen’s Birthday Honours List. He was appointed a Member of the Order of the British Empire (MBE) for services to public health and UK/Vietnam relations. Professor Thwaites has been the Director of OUCRU since 2013. He is responsible for the scientific strategy and leadership […]

Evaluation of New Diagnostics for Active and Incident TB (ENDxTB)

To improve the diagnosis of all forms of TB at any age, the OUCRU TB team is participating in the international ENDxTB project, funded 2020 – 2025 by NIH. We provide clinical experience and laboratory skills to evaluate field-ready diagnostic tests and platforms for TB in Vietnam, in collaboration with Pham Ngoc Thach Hospital and […]

Skip to content